Literature DB >> 8038146

A case of cerebral infarction associated with positive antiphospholipid antibody in a systemic lupus patient.

E R Jo1, H J Shin, J H Seo, S H Lee, G G Song, H J Pyo.   

Abstract

Antiphospholipid antibody syndrome is a newly-defined clinical entity of arterial thrombosis, venous thrombotic events, recurrent spontaneous abortion and thrombocytopenia in the presence of antiphospholipid antibodies. We have experienced a 23-year-old male SLE patient with positive anticardiolipin antibody who presented with left hemiparesis and paresthesia. The clinical and laboratory findings were compatible with the criteria for SLE and he was found to have anticardiolipin antibody, thrombocytopenia, prolonged partial thromboplastin time and cerebral thrombosis. Initially, he was treated with high dose steroid and warfarin and now he is being followed up with warfarin and steroid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038146      PMCID: PMC4532060          DOI: 10.3904/kjim.1994.9.1.43

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  14 in total

Review 1.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 2.  The clinical syndrome associated with antiphospholipid antibodies.

Authors:  M Petri
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

Review 3.  The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.

Authors:  S R Levine; K M Welch
Journal:  Arch Neurol       Date:  1987-08

Review 4.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

5.  Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Authors:  M H Rosove; P M Brewer
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

6.  Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

Authors:  H P McNeil; C N Chesterman; S A Krilis
Journal:  Br J Haematol       Date:  1989-12       Impact factor: 6.998

7.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

8.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

Review 9.  Neurologic complications of antiphospholipid antibodies.

Authors:  R L Brey; A E Gharavi; M D Lockshin
Journal:  Rheum Dis Clin North Am       Date:  1993-11       Impact factor: 2.670

10.  Ocular thrombosis associated with antiphospholipid antibodies.

Authors:  S L Galetta; G L Plock; M J Kushner; R E Wyszynski; A J Brucker
Journal:  Ann Ophthalmol       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.